Accelerated Neuromodulation of Anterior Cingulate Cortex for Depression — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Accelerated Neuromodulation of Anterior Cingulate Cortex for Depression — Stella

Home/Major Depressive Disorder (MDD)/

View on ClinicalTrials.gov

Recruiting

Back to Major Depressive Disorder (MDD) trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Canada

Rotman Research Institute at Baycrest, Toronto, Ontario

Key details

Sponsor

Rotman Research Institute at Baycrest

Enrollment target

~24 participants

Started

July 2025

Primary completion

January 2027

Age range

60 Years – 85 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.